Prime causes of this are a fast progression of the tumor and the resistance to temozolomide caused by expression of O6-methylguanine-DNA methyltransferase (MGMT) reversing the changes in DNA caused by the drug, which occurs in most cases of high-grade gliomas [28,29,30]. The gene discussed is MGMT; the disease is neoplasm.